IBRNvsLABU
iShares Neuroscience and Healthcare ETF against DIREXION DAILY S&P BIOTECH BULL 3X SHARES — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | LABU | |
|---|---|---|
| Expense ratio | 0.47% | — |
| Assets | $6640.17T | $594M |
| Net flow, 1 month | +$94K | +$107M |
| Net flow, 1 year | +$2M | −$911M |
| Return, YTD | +0.7% | +66.8% |
| Return, 1 year | +18.6% | +164.6% |
| Avg daily volume | 2K | 340K |
| Holdings | 54 | 134 |
| Listed | Aug 24, 2022 | Nov 27, 2023 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS